BE583960A - Procédé de préparation de 1,2-méthylène-3-cétostéroïdes - Google Patents

Procédé de préparation de 1,2-méthylène-3-cétostéroïdes

Info

Publication number
BE583960A
BE583960A BE583960A BE583960A BE583960A BE 583960 A BE583960 A BE 583960A BE 583960 A BE583960 A BE 583960A BE 583960 A BE583960 A BE 583960A BE 583960 A BE583960 A BE 583960A
Authority
BE
Belgium
Prior art keywords
ketosteroids
methylene
preparing
Prior art date
Application number
BE583960A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DESCH26339A external-priority patent/DE1096353B/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of BE583960A publication Critical patent/BE583960A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
BE583960A 1958-10-25 1959-10-23 Procédé de préparation de 1,2-méthylène-3-cétostéroïdes BE583960A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DESC024917 1958-10-25
DESCH26339A DE1096353B (de) 1959-07-11 1959-07-11 Verfahren zur Herstellung von 1, 2-Methylen-3-ketosteroiden

Publications (1)

Publication Number Publication Date
BE583960A true BE583960A (fr) 1960-04-25

Family

ID=25992757

Family Applications (1)

Application Number Title Priority Date Filing Date
BE583960A BE583960A (fr) 1958-10-25 1959-10-23 Procédé de préparation de 1,2-méthylène-3-cétostéroïdes

Country Status (4)

Country Link
BE (1) BE583960A (fr)
CH (1) CH376905A (fr)
DK (1) DK110082C (fr)
GB (1) GB926372A (fr)

Also Published As

Publication number Publication date
CH376905A (de) 1964-04-30
DK110082C (da) 1968-09-23
GB926372A (en) 1963-05-15

Similar Documents

Publication Publication Date Title
BE582479A (fr) Procédé de préparation de diamants.
BE579006R (fr) Procédé de préparation d'esters.
FR1208123A (fr) Procédé de préparation de 4-nitro-diarylamines
FR1200540A (fr) Procédé de préparation du 1.1.1-trifluoro-2-chloro-2-brométhane
CH367825A (fr) Procédé de préparation de 1,4-stéroïdes
FR1230823A (fr) Procédé de préparation des 1,4-dicyanobutènes
CH387297A (fr) Procédé de préparation de polyuréthane-semicarbazides
FR1221294A (fr) Procédé de préparation de tétrahydro-oxazines substituées
BE597448A (fr) Procédé de préparation d'O.N-dialcoyl-hydroxylamines.
FR1268422A (fr) Procédé de préparation de prégnadiènes-1, 4
BE583960A (fr) Procédé de préparation de 1,2-méthylène-3-cétostéroïdes
FR1305310A (fr) Procédé de préparation de 3, 4, 6-trioxohexahydropyridazines substituées
BE584359A (fr) Procédé de préparation de la 2,5-bis-éthylène-imino-3,6-bis-caproylamino-p-benzoquinone
CH387198A (fr) Procédé de préparation de disazopyrazolones
BE581689A (fr) Procédé de préparation de caféine-(8)-alcanolamines.
FR1220994A (fr) Procédé de préparation des 1,4-prégnadiènes
FR1276851A (fr) Procédé de préparation du 2, 3-dicyan-1, 4-dithia-anthrahydroquinone et -anthraquinone
FR1248430A (fr) Procédé de préparation de 2,6-dialcoyl-benzo [1, 2, 4, 5] bis-imidazoles
BE592835A (fr) Procédé de préparation de l'adipo-dinitrile.
FR1230797A (fr) Procédé de préparation de cyanéthyl-polyamides
FR1330115A (fr) Procédé de préparation de 2:6-dihydroxypyrimidines
FR1281233A (fr) Procédé de préparation de 18, 20-cyclo-20-oxo-21-nor-prégnanes
FR1273866A (fr) Procédé de préparation de la 3-sulfanilamido-6-méthoxy-pyridazine
FR1271489A (fr) Procédé de préparation de la 11alpha-hydroxy-17alpha-méthyl-testostérone
FR1240188A (fr) Procédé de préparation de la beta-p-nitrophénylsérine